Choosing a breast implant involves the exact device, its safety information and your anatomy—not a universal ranking of brands. Use a consultation to compare suitable options and understand the longer-term follow-up.
Key points
- Ask for the manufacturer, exact model and current patient information.
- Breast implants are not lifetime devices; further surgery may be needed.
- An old brand list may include recalled devices and should not guide a purchase.
On this page
Start with the exact device
A brand name alone does not identify an implant. Ask the surgeon to explain the proposed filling, surface, shape and size, and how these fit your tissues and goals. Request the patient information for that particular device and keep its identification details after surgery.
Why older brand comparisons can be misleading
The FDA’s published implant information includes product labelling for several manufacturers. This is a way to locate device-specific information, rather than a league table or confirmation that every listed model is currently available in Iran. Local authorisation, supply and the exact proposed product must be checked with the treating facility. [1]
The BIOCELL recall must not be omitted
Allergan’s BIOCELL textured breast implants and tissue expanders were recalled because of the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Smooth-surface implants were not included in that recall. An older article describing BIOCELL or Natrelle 410 as an ordinary new-treatment option is therefore unsuitable for choosing a device. If you already have implants, take the device records to your clinician and discuss your individual situation. [2]
Discuss follow-up and possible further treatment
Ask about rupture, capsular contracture, changes in sensation, scarring and the possibility of revision or removal. Implants are not lifetime devices. The follow-up plan should identify who will review you after returning home and which changes should prompt assessment. [3]
What to include in a written quote
Confirm the surgeon, facility, exact proposed device, anaesthesia, follow-up appointments and any separate practical services. Ask what happens if the clinical assessment changes the plan. A price comparison is meaningful only when these details are clear; there is no single best implant or fixed package that suits everyone.
Plan your consultation
Explore treatments · Contact SanaMedTour
Sources
[1] FDA: Device-specific breast implant labelling · ↑ Back to text
[2] FDA: Allergan BIOCELL recall · ↑ Back to text
[3] FDA: Breast implant safety information · ↑ Back to text
Editorial update: 25 October 2026. General information for discussion with a qualified clinician; individual instructions take priority.